Iovance Biotherapeutics to Present at Upcoming Conferences

SAN CARLOS, Calif., Dec. 07, 2021 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, today announced participation in the following conferences in December:

Click to view original post